Windlas Biotech Ipo Gmp - Subscribe To Windlas Biotech Kr Choksey 24htech Asia - The windlas biotech ipo will hit the market soon, and you can apply for the ipo from 4th august to 6th august 2021.

Windlas Biotech Ipo Gmp - Subscribe To Windlas Biotech Kr Choksey 24htech Asia - The windlas biotech ipo will hit the market soon, and you can apply for the ipo from 4th august to 6th august 2021.. Windlas biotech ipo to hit the market on 04 august 2021 and closes on 06 august 2021 as the dates are officially announced in rhp. Let's see what number is stable. Windlas biotech is the top pharmaceutical lead company in india. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. The company was incorporated as 'windlas biotech limited' at new delhi as a public limited company.

The issue is priced at ₹448 to ₹460 per equity share. The company received the certificate for commencement of business from the roc delhi. Windlas biotech ipo gmp (grey market price) according to reports that have surfaced so far, the grey market has reached a premium of ₹135 to ₹40 even before it opened for subscriptions to ipo. The issue is priced at . to . per equity share. Windlas biotech limited is going public with its initial public offering (ipo) on august 4 and it will close its subscription on august 6.

Windlas biotech ipo gmp (grey market price) according to reports that have surfaced so far, the grey market has reached a premium of ₹135 to ₹40 even before it opened for subscriptions to ipo. Windlas biotech ipo is going to hit the market on 04 aug 2021 and closes on 06 aug 2021. The registered office of the company was shifted from the state of delhi to the state of uttarakhand. The grey market premium (gmp) for the windlas biotech ipo was listed as rs 150 on august 3, as per ipo watch. This company not perches medicine to other pharma company. The grey market premium (gmp) for the windlas biotech ipo was listed as rs 150 on august 3, as per ipo watch. For the unversed, the gmp is an unofficial platform. The ipo opens on aug 4, 2021, and closes on aug 6, 2021.

The anchor bookings for the ipo, if any, would have taken place on august 3, before the opening day.the price band of the issue stood at rs 448 to rs 460 per equity share.

The ipo comprises fresh issuance of equity shares worth ₹ 165 crore and and an offer for. Windlas biotech limited launched its initial public offering (ipo) on august 4. Windlas biotech is working on manufacture medicine and other biotech products. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. Windlas biotech grey market premium (gmp) is around ₹ 130 today. Windlas biotech is coming up with ipo that would open for subscription on 4th august 2021. The ipo gmp started and its on a higher side. The issue is priced at . to . per equity share. Windlas biotech ipo gmp is started at good numbers as expected. Windlas biotech analysis ipo @ chanakyanipothi.com, india`s oldest & most trusted investment blog.operational since 8th december 1999, this is the only investment platform in india, which has successfully completed 21 years. The issue is priced at ₹448 to ₹460 per equity share. The minimum order quantity is. We share the gmp information for educational purposes only, so that, you can make an informed decision.

The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. For the unversed, the gmp is an unofficial platform. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The issue is priced at ₹448 to ₹460 per equity share. Windlas biotech is the top pharmaceutical lead company in india.

We neither trade nor encourage our readers to trade in the grey market. The company to raise ₹401.654 crore via ipo that comprises ₹165 crore via fresh issue and offer for sale will be 5,142,067 shares. The issue is priced at . to . per equity share. Windlas biotech ipo gmp is started at good numbers as expected. The registered office of the company was shifted from the state of delhi to the state of uttarakhand. May 15, 2021 by profitmust. The ipo gmp started and its on a higher side. Windlas biotech analysis ipo @ chanakyanipothi.com, india`s oldest & most trusted investment blog.operational since 8th december 1999, this is the only investment platform in india, which has successfully completed 21 years.

The ipo opens on aug 4, 2021, and closes on aug 6, 2021.

The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. Grey market premium (gmp) today: Windlas biotech ipo gmp is started at good numbers as expected. Any anchor bookings that might take place would happen on august 3, before the opening day. Windlas biotech ipo to hit the market on 04 august 2021 and closes on 06 august 2021 as the dates are officially announced in rhp. Also, check ipo gmp for upcoming ipos. Windlas biotech ipo will hit the market in 2021. The issue is priced at . to . per equity share. Windlas biotech limited launched its initial public offering (ipo) on august 4. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Windlas biotech grey market newstoday # on 2.08.21 grey market premium rs. The ipo to raise ₹401.54 crores via ipo. The ipo will be open for subscriptions for three days and close on friday, august 6.

This company not perches medicine to other pharma company. The company to raise ₹401.654 crore via ipo that comprises ₹165 crore via fresh issue and offer for sale will be 5,142,067 shares. Windlas biotech ipo is going to hit the market on 04 aug 2021 as per the market speculations. Windlas biotech ipo gmp (grey market price) according to reports that have surfaced so far, the grey market has reached a premium of ₹135 to ₹40 even before it opened for subscriptions to ipo. Grey market premium (gmp) today:

Ipo Grey Market Premium Latest Ipo Gmp Kostak Rates Ipo Watch from 1.bp.blogspot.com

Windlas biotech ipo is going to hit the market on 04 aug 2021 as per the market speculations. Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders. Windlas biotech is the top pharmaceutical lead company in india. The company to raise ₹401.54 crores (approx) via initial public offer with a face value of ₹5 per equity share. Also, check ipo gmp for upcoming ipos. Windlas biotech analysis ipo @ chanakyanipothi.com, india`s oldest & most trusted investment blog.operational since 8th december 1999, this is the only investment platform in india, which has successfully completed 21 years. May 15, 2021 by profitmust. The anchor bookings for the ipo, if any, would have taken place on august 3, before the opening day.the price band of the issue stood at rs 448 to rs 460 per equity share.

Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders.

Also, check ipo gmp for upcoming ipos. The anchor bookings for the ipo, if any, would have taken place on august 3, before the opening day.the price band of the issue stood at rs 448 to rs 460 per equity share. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. Windlas biotech is planning to raise ₹401.54 crores through an ipo which consists of a fresh issue of ₹165 crores worth equity and ofs (offer for sale) of ₹236.54 by existing shareholders. The minimum order quantity is 30 shares. The ipo gmp started and its on a higher side. The issue is priced at . to . per equity share. The cap price for windlas biotech ipo is 460.estimated listing price for windlas biotech ipo as of current gmp is 610.expected gain/loss per share in terms of percentage is 32.61%. Windlas biotech is working on manufacture medicine and other biotech products. The ipo opens on aug 4, 2021, and closes on aug 6, 2021. The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. This company not perches medicine to other pharma company. Windlas biotech limited launched its initial public offering (ipo) on august 4.

Location:

Books PDF, ePub and Mobi Free Download